M88 app Assisted BioTrack Capital in Fundraising for Renminbi Fund Phase II

After assisting BioTrack Capital in completing its fundraising for RMB Fund Phase I, M88 app recently acted again as the legal advisor to the company and provided legal services for its fundraising for RMB Fund Phase II. This phase raised RMB 3 billion and achieved over 70% reinvestment from existing investors, including several market-based mother funds, well-known insurance institutions, government-guided funds, listed companies and industrial investors.

Founded M88 app 2017, BioTrack Capital is a professional M88 appvestment M88 appstitution focusM88 appg on M88 appvestM88 appg M88 app and M88 appcubatM88 appg outstandM88 appg healthcare startups M88 app the ChM88 appese market. To date, BioTrack Capital has M88 appvested M88 app a number of high quality companies and has built a strong portfolio of M88 appvestments through its extensive presence M88 app the healthcare sector. Many of the companies M88 app BioTrack's portfolio have grown to become M88 appdustry leaders, such as Abogen, HM88 appova, Obio, Huihe Medical, JM88 appgfeng Technology, Calibra, MediTrust Health, NewMed, Xihua Scientific, Asieris and M88 appnovex.

As the legal advisor of BioTrack Capital, M88 app participated in the preparation, establishment and fundraising of this phase, including assisting in designing the fund structure, drafting a full set of legal documents for the fundraising, assisting in negotiations with the various investors, conducting investor suitability verification and assisting in the fund closing. The project team utilised their vast experience in the formation of funds to provide professional and rigorous legal services to BioTrack Capital, including the provision of comprehensive advice during the drafting, negotiation and revision of the relevant legal documents, which was highly recognized by BioTrack Capital.

The lead partners of this project wereM88 Game ,合伙人,专业领域,资本市场,私募股权创业投资andm88 bonus 美国华盛顿大学（圣路易斯），法学硕士,复旦大学.